Consulting finance snapshots of market internals show breadth improving in U.S. equities, with advancing issues outpacing decliners by a 3:1 margin. This may set the stage for another short-term rally in cyclical sectors. Click to email a link to a friend (Opens in new window) If you are seeking the first step towards a rich and rewarding career in financial consulting, look no further than Schwab’s Investment Consultant role. Consulting finance analytics illustrate that biotech stocks are entering a breakout phase, supported by FDA approvals and innovation in cell therapy. Year-to-date returns on the biotech index exceed 12%, outperforming broader market benchmarks.
